×

Susceptibility mutation 6495delGC of BRCA2

DC
  • US 6,492,109 B1
  • Filed: 09/21/1998
  • Issued: 12/10/2002
  • Est. Priority Date: 09/23/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. An isolated oligonucleotide that specifically hybridizes to a BRCA2 nucleotide sequence, wherein the BRCA2 nucleotide sequence comprises a two nucleotide deletion corresponding to positions 8 and 9 of SEQ ID NO:

  • 3, relative to a BRCA2 nucleotide sequence that does not contain the deletion.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×